Sasanka Ramanadham, Ph.D., and researchers published “Selective Reduction of Ca2+-Independent Phospholipase A2β (iPLA2β)-Derived Lipid Signaling from Macrophages Mitigates Type 1 Diabetes Development"in the peer-reviewed journal Diabetes.

UAB Comprehensive Diabetes Center (UCDC) Director Anath Shalev, M.D., has secured a $3 million National Institutes of Health (NIH) multi-PI R01 grant to study the effectiveness of TIX100, originally developed as an antidiabetic, in treating MASLD and MASH.

Many with Type 1 diabetes (T1D) know that exercising can be a bit tricky for the management of glucose. For instance, some types of physical activity might cause blood glucose to drop while engaging in other types of physical activity might not, and it can be difficult to anticipate blood glucose trends during exercise.

Fernando Bril, M.D., and colleagues recently investigated the relationship between insulin resistance and metabolic dysfunction-associated steatotic liver disease (MASLD). 

Haifa "Saba" Alsharif, a fifth-year graduate student in Dr. Sushant Bhatnagar's Lab, was awarded a UAB Graduate Biomedical Sciences (GBS) award for mentorship at the 2024 symposium.

Fernando Ovalle, M.D., director of the UAB Division of Endocrinology, Diabetes, and Metabolism, and associate director of the UAB Comprehensive Diabetes Center (UCDC) recently published findings comparing insulin options for Type 1 diabetes (T1D) patients.

Sushant Bhatnagar, Ph.D., associate professor in the Division of Endocrinology, Diabetes, and Metabolism and scientist in the UAB Comprehensive Diabetes Center (UCDC) received pilot funding for his project “The role of brain angiogenesis inhibitor-3 GPCR signaling in adipose tissues.”

U.S. News & World Report (USNWR) recently ranked UAB Hospital as the best hospital in Alabama, naming several of its specialties as top-ranking in the nation. UAB Hospital’s diabetes and endocrinology specialty was ranked as high performing, the highest classification.

Ambika Ashraf, M.D., division director of UAB Pediatric Endocrinology and Ralph Frohsin Endowed Chair in Pediatric Endocrinology, has delved into the intricate world of the gut microbiota (GM) and its profound impact on obesity, metabolic syndrome (MS), and Type 2 diabetes (T2D).